Puma Biotechnology, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2023
Total Assets: $230.5M
Liabilities Breakdown FY2023
Total Liabilities: $177.1M
Asset Breakdown
Total Assets: $230.5M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $84.6M | 36.7% |
| Accounts Receivable | $47.8M | 20.8% |
| Inventory | $7.1M | 3.1% |
| Property, Plant & Equipment | $855.0K | 0.4% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $60.9M | 26.4% |
| Other Assets | $29.3M | 12.7% |
Liabilities Breakdown
Total Liabilities: $177.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $6.9M | 3.9% |
| Long-Term Debt | $65.7M | 37.1% |
| Other Liabilities | $104.5M | 59.0% |